These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 9553667)

  • 61. Suramin inhibits the growth of human breast cancer cell lines. Studies on parental lines and corresponding sublines with acquired doxorubicin resistance with and without expression of P-glycoprotein.
    Lindman H; Taube A; Bergh JC
    Anticancer Res; 1994; 14(2A):363-6. PubMed ID: 7912491
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
    Bronzert DA; Greene GL; Lippman ME
    Endocrinology; 1985 Oct; 117(4):1409-17. PubMed ID: 4029083
    [TBL] [Abstract][Full Text] [Related]  

  • 63. IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation.
    Zheng Y; Sowers JY; Houston KD
    Front Endocrinol (Lausanne); 2020; 11():233. PubMed ID: 32435229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells.
    Ignatov A; Ignatov T; Roessner A; Costa SD; Kalinski T
    Breast Cancer Res Treat; 2010 Aug; 123(1):87-96. PubMed ID: 19911269
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast-cancer cells: modulation by steroidal and non-steroidal therapeutic agents.
    Purohit A; Reed MJ
    Int J Cancer; 1992 Apr; 50(6):901-5. PubMed ID: 1532568
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of tamoxifen on human squamous cell carcinoma lines of the head and neck.
    Hoffmann TK; Bojar H; Eckel J; van Lierop A; Balz V; Friebe-Hoffmann U; Hauser U; Bier H
    Anticancer Drugs; 2002 Jun; 13(5):521-31. PubMed ID: 12045464
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanism of growth inhibition by calpain inhibitor in MCF-7 cells.
    Shiba E; Kim SJ; Kambayashi J; Kawamura I; Lacey E; Manda T; Shimomura K; Taguchi T; Takai S
    Anticancer Res; 1997; 17(3C):1919-23. PubMed ID: 9216645
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer.
    Chu I; Blackwell K; Chen S; Slingerland J
    Cancer Res; 2005 Jan; 65(1):18-25. PubMed ID: 15665275
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7.
    Chiarenza A; Lazarovici P; Lempereur L; Cantarella G; Bianchi A; Bernardini R
    Cancer Res; 2001 Apr; 61(7):3002-8. PubMed ID: 11306479
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modulation by oestrogen and progestins/antiprogestins of alpha interferon receptor expression in human breast cancer cells.
    Martin JH; McKibben BM; Lynch M; van den Berg HW
    Eur J Cancer; 1991; 27(2):143-6. PubMed ID: 1827277
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M; Bicknell R; Harris AL
    Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumor promoters in human mammary carcinoma cells.
    Roos W; Fabbro D; Küng W; Costa SD; Eppenberger U
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):991-5. PubMed ID: 3006036
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells.
    Sica G; Iacopino F; Robustelli della Cuna G; Marchetti P; Marini L
    J Cancer Res Clin Oncol; 1994; 120(10):605-9. PubMed ID: 7929532
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
    Tsonis AI; Afratis N; Gialeli C; Ellina MI; Piperigkou Z; Skandalis SS; Theocharis AD; Tzanakakis GN; Karamanos NK
    FEBS J; 2013 May; 280(10):2248-59. PubMed ID: 23374155
    [TBL] [Abstract][Full Text] [Related]  

  • 76. erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
    Knowlden JM; Gee JM; Barrow D; Robertson JF; Ellis IO; Nicholson RI; Hutcheson IR
    Breast Cancer Res; 2011 Sep; 13(5):R93. PubMed ID: 21939528
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells.
    Riggs KA; Wickramasinghe NS; Cochrum RK; Watts MB; Klinge CM
    Cancer Res; 2006 Oct; 66(20):10188-98. PubMed ID: 17047084
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Modulating effect of vitamin D3 in vitro on EGFR mRNA expression of human breast cancer cell lines].
    Zhang L; Zhai X; He Z
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):205-7. PubMed ID: 11778232
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    Kijima I; Itoh T; Chen S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells.
    Wosikowski K; Silverman JA; Bishop P; Mendelsohn J; Bates SE
    Biochim Biophys Acta; 2000 Jul; 1497(2):215-26. PubMed ID: 10903426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.